Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2013 Apr 1;98(1):5-6.
doi: 10.1093/cvr/cvt039. Epub 2013 Mar 1.

Multi-channel blockers for treatment of atrial fibrillation: an effective strategy?

David R Van Wagoner
Editorial

Multi-channel blockers for treatment of atrial fibrillation: an effective strategy?

David R Van Wagoner. Cardiovasc Res. .
No abstract available

PubMed Disclaimer

Comment on

References

    1. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, et al. Heart disease and stroke statistics—2013 update: a report from the american heart association. Circ. 2013;127:e6–e245. doi:10.1161/CIR.0b013e31828124ad. - DOI - PMC - PubMed
    1. Wettwer E, Christ T, Endig S, Rozmaritsa N, Matschke K, Lynch JJ, et al. The new antiarrhythmic drug Vernakalant: ex vivo study of human atrial tissue from sinus rhythm and chronic atrial fibrillation. Cardiovasc Res. 2013;98:145–154. - PubMed
    1. Suzuki T, Morishima M, Kato S, Ueda N, Honjo H, Kamiya K. Atrial selectivity in Na+ channel blockade by acute amiodarone. Cardiovasc Res. 2013;98:136–144. - PubMed
    1. Maintenance of sinus rhythm in patients with atrial fibrillation: an AFFIRM substudy of the first antiarrhythmic drug. J Am Coll Cardiol. 2003;42:20–29. doi:10.1016/S0735-1097(03)00559-X. - DOI - PubMed
    1. Santangeli P, Di BL, Burkhardt JD, Bai R, Mohanty P, Pump A, et al. Examining the safety of amiodarone. Expert Opin Drug Saf. 2012;11:191–214. doi:10.1517/14740338.2012.660915. - DOI - PubMed